volume 294, issue 6588, P1660-1660 1987
DOI: 10.1136/bmj.294.6588.1660
View full text
|
|
Share
J Woolf, I C McManus

Abstract: implications regarding the metabolic defect responsible for the clinical features of Huntington's disease. It also suggests a role for manipulation of the striatonigral neurotransmitter pathway in treatment and presymptomatic testing for this condition.